Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sengottayan VK et al. - The authors have assessed the usefulness of celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in the management of refractory nocturia in patients with benign prostatic hyperplasia (BPH). Celecoxib was an effective treatment option for patients with BPH with nocturia.

Today in Voiding Dys/Incontinence...keeping you current

Current status of 5[alpha]-reductase inhibitors in the management of lower urinary tract symptoms and BPH
World Journal of Urology, 12/10/09

Transobturator Tape Compared With Tension-Free Vaginal Tape for Stress Incontinence: A Randomized Controlled Trial
Obstetrics and Gynecology, 12/10/09

Whole-Genome Linkage and Association Scan in Primary, Nonsyndromic Vesicoureteric Reflux
Journal of the American Society of Nephrology, 12/10/09